Given that NF‐kB is activated in stromal myofibroblasts surrounding colon adenocarcinomas promoting migration and invasion of CRC cells [19], it has been suggested that there is potential use of tamarixetin as a template for novel therapeutic applications toward treatment and/or prevention of CRC. Here, NFKB1 is linked to colorectal carcinoma.